These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 29339419

  • 1. LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.
    Huang Y, Luo H, Li F, Yang Y, Ou G, Ye X, Li N.
    Biosci Rep; 2018 Jun 29; 38(3):. PubMed ID: 29339419
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H, Chen W, Yang P, Zhou J, Wang K, Tao Q.
    Cancer Biol Ther; 2019 Jun 29; 20(4):461-473. PubMed ID: 30404587
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LINC00152 promotes the proliferation of gastric cancer cells by regulating B-cell lymphoma-2.
    Mao Y, Tie Y, Du J, He J.
    J Cell Biochem; 2019 Mar 29; 120(3):3747-3756. PubMed ID: 30304559
    [Abstract] [Full Text] [Related]

  • 10. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH, Lo YH, Wang KC, Kang CH, Tsai CY, Tsai KW.
    Anticancer Res; 2018 Jun 29; 38(6):3309-3318. PubMed ID: 29848678
    [Abstract] [Full Text] [Related]

  • 11. lncRNA-MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR-29a-3p/HDAC4 axis.
    Li Y, Wang K, Wei Y, Yao Q, Zhang Q, Qu H, Zhu G.
    Oncol Rep; 2017 Dec 29; 38(6):3465-3472. PubMed ID: 29039602
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.
    Ren P, Niu X, Zhao R, Liu J, Ren W, Dai H, Chen J, Yan J, Li B, Shao Y, Bai Y, Han P.
    Cell Cycle; 2022 Apr 29; 21(7):697-707. PubMed ID: 35113007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
    Williams M, Kirschner MB, Cheng YY, Hanh J, Weiss J, Mugridge N, Wright CM, Linton A, Kao SC, Edelman JJ, Vallely MP, McCaughan BC, Cooper W, Klebe S, Lin RC, Brahmbhatt H, MacDiarmid J, van Zandwijk N, Reid G.
    Oncotarget; 2015 Sep 15; 6(27):23480-95. PubMed ID: 26125439
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
    Kan L, Yang M, Zhang H.
    Biol Direct; 2023 Jul 04; 18(1):36. PubMed ID: 37403106
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.
    Li D, Li Q.
    Bioengineered; 2022 Mar 04; 13(3):6509-6520. PubMed ID: 35226830
    [Abstract] [Full Text] [Related]

  • 18. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
    Chen P, Fang X, Xia B, Zhao Y, Li Q, Wu X.
    Cancer Med; 2018 Sep 04; 7(9):4530-4541. PubMed ID: 30030896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
    Hiraide S, Takahashi M, Yoshida Y, Yamada H, Komine K, Ishioka C.
    Cancer Sci; 2021 Sep 04; 112(9):3856-3870. PubMed ID: 34288281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.